Background: Premature ovarian failure (POF) is a condition caused by ovarian insuffiency during the reproductive age that affects ~1% of women globally. Many attempts have been collected to find feasible and effective approach to reduce POF consequences in females. In this regard, cell-based therapies with certain cell types are touted as novel and hopeful therapeutic intervention in the clinical setting. Methods: To evaluate the restoration of ovarian function after intra-ovarian transplantation of bone marrow-derived c-Kit+ cells, a rat model of ovarian failure was produced. Rats were treated with 160 mg/kg/BW of 4-vinylcyclohexene dioxide (VCD) for 15 consecutive days. Using magnetic-activated cell sorting (MACS) technique, freshly isolated rat bone marrow-derived c-Kit+ and c-Kit- cells (4×105 cells/10 µL) were enriched and transplanted into the ovaries of treatment and control animals, respectively. Prior to transplantation as well as 2, 4, 6, and 8 weeks post-transplantation, randomly-selected rats were euthanized and ovarian tissues were subjected to pathohistological examinations and real-time PCR analyses.Results: Premature ovarian failure (POF) status was confirmed by the presence of pathological features and a decreased number of immature and mature follicles compared with control group (p<0.05). Histological examination revealed a substantial reduction of atretic follicles in POF rats receiving c-Kit+ cells in comparison with POF rats that did not receive these cells (p<0.05). Compared with control samples, angiogenesis-related genes, Angpt2 and KDR, showed increased and decreased expression in POF ovaries, respectively (p<0.05). c-Kit+ cells had potential to restore angiogenesis in the ovarian tissue to within normal ranges. Systemic levels of FSH did not significantly change in pre- or post-transplantation time points for any group (p>0.05). Notable reduction of collagen deposition was found in c-Kit treated rats. Transplantation of c-Kit+ cells also restored the reduced fertility rate (p<0.05).Conclusions: Our findings suggest that intra-ovarian administration of bone marrow-derived c-Kit+ cells can modulate angiogenesis signaling and pathological changes, leading to the rejuvenation of ovarian function of a rat model of premature menopause.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.